Diabetic cataracts: mechanisms and management

被引:171
作者
Obrosova, Irina G. [1 ]
Chung, Stephen S. M. [2 ]
Kador, Peter F. [3 ,4 ]
机构
[1] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA
[2] Univ Hong Kong, Dept Physiol, Hong Kong, Peoples R China
[3] Univ Nebraska, Med Ctr, Coll Pharm, Dept Pharmaceut Sci, Omaha, NE USA
[4] Univ Nebraska, Med Ctr, Coll Med, Dept Ophthalmol, Omaha, NE USA
关键词
lens; diabetic cataract; anticataract agents; ALDOSE REDUCTASE INHIBITOR; GLYCATION END-PRODUCTS; LENS PROTEIN OXIDATION; TERM NUTRIENT INTAKE; NITROSATIVE STRESS; POLYOL PATHWAY; RISK-FACTORS; POLY(ADP-RIBOSE) POLYMERASE; IMMUNOCHEMICAL DETECTION; ENERGY-METABOLISM;
D O I
10.1002/dmrr.1075
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes mellitus is associated with a 5-fold higher prevalence of cataracts, which remains a major cause of blindness in the world. Typical diabetic cataracts contain cortical and/or posterior subcapsular opacities. Adult onset diabetic cataracts also often contain nuclear opacities. Mechanisms of diabetic cataractogenesis have been studied in less detail than those of other diabetic complications. Both animal and human studies support important contribution of increased aldose reductase activity. Surgical extraction is the only cure of diabetic cataract today. An improved understanding of pathogenetic mechanisms, together with finding effective therapeutic agents, remain highest priority for diabetic cataract-related research and pharmaceutical development. Copyright (C) 2010 John Wiley & Sons, Ltd.
引用
收藏
页码:172 / 180
页数:9
相关论文
共 124 条
  • [51] A 30 YEAR JOURNEY IN THE POLYOL PATHWAY
    KINOSHITA, JH
    [J]. EXPERIMENTAL EYE RESEARCH, 1990, 50 (06) : 567 - 573
  • [52] ALDOSE REDUCTASE IN THE DIABETIC EYE - 43RD JACKSON,EDWARD MEMORIAL LECTURE
    KINOSHITA, JH
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1986, 102 (06) : 685 - 692
  • [53] Klein B E, 1995, Ophthalmic Epidemiol, V2, P49, DOI 10.3109/09286589509071451
  • [54] KLEIN BEK, 1985, OPHTHALMOLOGY, V92, P1191
  • [55] KLEIN R, 1995, NIH PUBLICATION, P293
  • [56] Epithelial cell density in cataractous lenses of patients with diabetes: Association with erythrocyte aldose reductase
    Kumamoto, Yuko
    Takamura, Yoshihiro
    Kubo, Eri
    Tsuzuki, Syousai
    Akagi, Yoshio
    [J]. EXPERIMENTAL EYE RESEARCH, 2007, 85 (03) : 393 - 399
  • [57] Electrophoretic analysis of oxidatively modified eye lens proteins in vitro:: implications for diabetic cataract
    Kysel'ová, Z
    Krizanová, L
    Soltés, L
    Stefek, M
    [J]. JOURNAL OF CHROMATOGRAPHY A, 2005, 1084 (1-2) : 95 - 100
  • [58] Temporal relationship between lens protein oxidation and cataract development in streptozotocin-induced diabetic rats
    Kyselová, Z
    Garcia, SJ
    Gajdosíková, A
    Gajdosík, A
    Stefek, M
    [J]. PHYSIOLOGICAL RESEARCH, 2005, 54 (01) : 49 - 56
  • [59] Kyselova Z, 2005, MOL VIS, V11, P56
  • [60] Fructose-3-phosphate production and polyol pathway metabolism in diabetic rat hearts
    Lal, S
    Randall, WC
    Taylor, AH
    Kappler, F
    Walker, M
    Brown, TR
    Szwergold, BS
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (11): : 1333 - 1338